Terms: = Thyroid cancer AND STIL, SIL, 6491, ENSG00000123473, Q15468 AND Treatment
6 results:
1. The clinical efficacy of Apatinib plus Ba Zhen granules in the treatment of advanced unresectable differentiated thyroid cancer and their influence on immune factors.
Bai Y; Jin J; Liu Y; Zhang B; Li J
Pak J Pharm Sci; 2023 May; 36(3(Special)):935-939. PubMed ID: 37587701
[TBL] [Abstract] [Full Text] [Related]
2. Establishment and validation of a LC-MS/MS method for the determination of anlotinib in human plasma: Application to therapeutic drug monitoring.
Yu M; Liang Z; Xiong L; Liu F; Cheng L; Jia C; Qi X; Sun F
Biomed Chromatogr; 2022 Dec; 36(12):e5501. PubMed ID: 36082703
[TBL] [Abstract] [Full Text] [Related]
3. Effects of Regional and General Anesthesia on the Therapeutic Outcome of Benign thyroid Nodules Treated with High Intensity Focused Ultrasound (HIFU).
Vorländer C; Fischer A; Korkusuz H
World J Surg; 2022 May; 46(5):1076-1081. PubMed ID: 35072745
[TBL] [Abstract] [Full Text] [Related]
4. Is dermolipectomy effective in improving insulin action and lowering inflammatory markers in obese women?
Rizzo MR; Paolisso G; Grella R; Barbieri M; Grella E; Ragno E; Grella R; Nicoletti G; D'Andrea F
Clin Endocrinol (Oxf); 2005 Sep; 63(3):253-8. PubMed ID: 16117810
[TBL] [Abstract] [Full Text] [Related]
5. The effects of thyroid hormones on circulating markers of cell-mediated immune response, as studied in patients with differentiated thyroid carcinoma before and during thyroxine withdrawal.
Botella-Carretero JI; Prados A; Manzano L; Montero MT; Escribano L; Sancho J; Escobar-Morreale HF
Eur J Endocrinol; 2005 Aug; 153(2):223-30. PubMed ID: 16061828
[TBL] [Abstract] [Full Text] [Related]
6. Low-dose IL-2 treatment: activation of discrete T- and NK-cell sub-populations in vivo.
Farace F; Angevin E; Dietrich PY; Leboullaire C; Vanderplancke J; Escudier B; Triebel F
Int J Cancer; 1995 Sep; 62(5):523-8. PubMed ID: 7665221
[TBL] [Abstract] [Full Text] [Related]